buparvaquone has been researched along with Leishmaniasis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bou-Chacra, N; Cotrim, PC; de Araújo, GLB; Fotaki, N; Löbenberg, R; Monteiro, LM | 1 |
1 other study(ies) available for buparvaquone and Leishmaniasis
| Article | Year |
|---|---|
Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment.
Topics: Anti-Bacterial Agents; Biopolymers; Chitosan; Dextrans; Drug Combinations; Drug Delivery Systems; Leishmania infantum; Leishmaniasis; Lipids; Nanostructures; Naphthoquinones; Particle Size; Polymyxin B; Thermogravimetry | 2019 |